Trilineage myelodysplasia and hemophagocytosis associated with systemic lupus erythematosus.
Department of Laboratory Medicine, The Ottawa Hospital, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, Canada. aleks.p@gmail.com
Aleksandra
A
Paliga
Nasim
N
Shahbazi
Carol
C
Gonsalves
Janis
J
Bormanis
Ruth
R
Padmore
D058186:Acute Kidney Injury / Q000209:etiology / Q000652:urine; D000328:Adult; D016913:Blood Component Transfusion; D001853:Bone Marrow / Q000473:pathology; D019070:Cell Lineage; D003131:Combined Modality Therapy; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006417:Hematuria / Q000209:etiology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications*; D008181:Lupus Nephritis / Q000150:complications / Q000652:urine; D051359:Lymphohistiocytosis, Hemophagocytic / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D010198:Pancytopenia / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000628:therapy; D010493:Pericarditis / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D000068256:Darbepoetin alfa; D009173:Mycophenolic Acid; D000069585:Filgrastim; D011241:Prednisone